656 - Pharmacokinetics of RLS-0071, a Novel Anti-Inflammatory Peptide, in Newborns With Moderate or Severe Hypoxic Ischemic Encephalopathy
Sunday, April 27, 2025
8:30am – 10:45am HST
Zachary A. Vesoulis, Washington University in St. Louis School of Medicine, St. Louis, MO, United States; Kenji Cunnion, Children's Hospital of The King's Daughters, Norfolk, VA, United States; Neel K. Krishna, ReAlta Life Sciences, Norfolk, VA, United States
